Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP888704.RA_4NGyCP1-SIbxuM9SWWCdsRj_eYIwzhHat7Ht8rTzZ0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP888704.RA_4NGyCP1-SIbxuM9SWWCdsRj_eYIwzhHat7Ht8rTzZ0130_assertion type Assertion NP888704.RA_4NGyCP1-SIbxuM9SWWCdsRj_eYIwzhHat7Ht8rTzZ0130_head.
- NP888704.RA_4NGyCP1-SIbxuM9SWWCdsRj_eYIwzhHat7Ht8rTzZ0130_assertion description "[When the severity of gastric atrophy was classified into the following three groups: non-atrophy (NA) (atrophy score=0 and metaplasia score=0); severe atrophy (SA) (atrophy score?2 or metaplasia score?2) and mild atrophy (MA) (all others), both the GSTT1 and GSTM1 null genotypes held significantly higher risk for developing more severe gastric atrophy (GSTT1 null, SA vs. others: OR=1.95, 95% CI=1.07-3.52, p=0.028, GSTM1 null, NA vs. others: OR=2.57, 95% CI=1.16-5.67, p=0.019, SA vs. others: OR=1.90, 95% CI=1.06-3.42, p=0.032).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP888704.RA_4NGyCP1-SIbxuM9SWWCdsRj_eYIwzhHat7Ht8rTzZ0130_provenance.
- NP888704.RA_4NGyCP1-SIbxuM9SWWCdsRj_eYIwzhHat7Ht8rTzZ0130_assertion evidence source_evidence_literature NP888704.RA_4NGyCP1-SIbxuM9SWWCdsRj_eYIwzhHat7Ht8rTzZ0130_provenance.
- NP888704.RA_4NGyCP1-SIbxuM9SWWCdsRj_eYIwzhHat7Ht8rTzZ0130_assertion SIO_000772 21508403 NP888704.RA_4NGyCP1-SIbxuM9SWWCdsRj_eYIwzhHat7Ht8rTzZ0130_provenance.
- NP888704.RA_4NGyCP1-SIbxuM9SWWCdsRj_eYIwzhHat7Ht8rTzZ0130_assertion wasDerivedFrom befree-2016 NP888704.RA_4NGyCP1-SIbxuM9SWWCdsRj_eYIwzhHat7Ht8rTzZ0130_provenance.
- NP888704.RA_4NGyCP1-SIbxuM9SWWCdsRj_eYIwzhHat7Ht8rTzZ0130_assertion wasGeneratedBy ECO_0000203 NP888704.RA_4NGyCP1-SIbxuM9SWWCdsRj_eYIwzhHat7Ht8rTzZ0130_provenance.